We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The investment seeks to track the investment results (before fees and expenses) of the WilderHill New Energy Global Innovation Index (the underlying index). The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index, as well as American depos... The investment seeks to track the investment results (before fees and expenses) of the WilderHill New Energy Global Innovation Index (the underlying index). The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index, as well as American depositary receipts (ADRs) and global depositary receipts (GDRs) that represent securities in the underlying index. The underlying index is comprised primarily of companies whose technologies focus on the generation and use of cleaner energy, conservation and efficiency, and the advancement of renewable energy in general, as determined by the index provider. Show more
Probiodrug / Probiodrug AG Reports Third Quarter 2018 Business Update . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement...
Probiodrug / Probiodrug AG to Publish its Third Quarter 2018 Business Update on November 29, 2018 . Processed and transmitted by West Corporation. The issuer is solely responsible for the...
Probiodrug / Probiodrug publishes SAPHIR data in peer reviewed journal . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement...
Probiodrug / Probiodrug AG: Loss announcement according to §92 paragraph 1 of the German Stock Corporation Act . Processed and transmitted by West Corporation. The issuer is solely responsible...
Probiodrug / Probiodrug Reports Management Changes . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Probiodrug Reports...
Probiodrug / Probiodrug Appoints Dr. Michael Schaeffer as Executive Vice President of Business and Strategy . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely...
Probiodrug / Probiodrug Reports Financial Results for H1 2018 and Corporate Update . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of...
Probiodrug / Probiodrug AG to Publish First Half 2018 Results on August 30, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this...
Probiodrug / Ordinary General Meeting of Shareholders of Probiodrug AG . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this...
Probiodrug / Probiodrug AG reports First Quarter 2018 Business Update . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.77 | -6.37417218543 | 12.08 | 12.08 | 10.57 | 61196 | 11.47601814 | SP |
4 | -0.57 | -4.79797979798 | 11.88 | 12.48 | 10.57 | 63735 | 11.74525057 | SP |
12 | -1.66 | -12.798766384 | 12.97 | 13.375 | 10.57 | 52478 | 12.00492827 | SP |
26 | -3.43 | -23.2700135685 | 14.74 | 14.74 | 10.57 | 38769 | 12.59698712 | SP |
52 | -3.1 | -21.5128383067 | 14.41 | 15.07 | 10.57 | 35847 | 13.22220899 | SP |
156 | -12.95 | -53.3800494641 | 24.26 | 26.05 | 10.57 | 39577 | 17.72221745 | SP |
260 | -3.88 | -25.543120474 | 15.19 | 41.26 | 9.7 | 65661 | 25.75534233 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions